Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 15 April 1983:
Vol. 220. no. 4594, pp. 304 - 306
DOI: 10.1126/science.6301002

Articles

Science, Vol 220, Issue 4594, 304-306
Copyright © 1983 by American Association for the Advancement of Science


articles

Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues

MV Haspel, T Onodera, BS Prabhakar, M Horita, H Suzuki, and AL Notkins

Mice infected with reovirus type 1 develop an autoimmune polyendocrine disease. Spleen cells from these mice were fused with myeloma cells and the culture fluids were screened by indirect immunofluorescence for autoantibodies reactive with normal mouse tissues. A large panel of cloned, stable antibody-producing hybridomas has been obtained. Fourteen of the hybridomas make autoantibodies that react with cells in the islets of Langerhans, 24 with cells in the anterior pituitary, 11 with cells in gastric mucosa, and 5 with nuclei. Except for the antibodies to nuclei, the monoclonal autoantibodies are organ-specific. Some, however, show broad cross-species reactivity, recognizing similar antigenic determinants in mouse, rat, pig, and human organs, whereas other recognize determinants only in rodent tissues. Several of the antigens recognized by these monoclonal autoantibodies have been identified as hormones (for example, glucagon, growth hormone, and insulin).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Reovirus Delays Diabetes Onset but Does Not Prevent Insulitis in Nonobese Diabetic Mice.
J. D. Wetzel, E. S. Barton, J. D. Chappell, G. S. Baer, M. Mochow-Grundy, S. E. Rodgers, Y. Shyr, A. C. Powers, J. W. Thomas, and T. S. Dermody (2006)
J. Virol. 80, 3078-3082
   Abstract »    Full Text »    PDF »
Endocrine Aspects of Cancer Gene Therapy.
L. Barzon, M. Boscaro, and G. Palu (2004)
Endocr. Rev. 25, 1-44
   Abstract »    Full Text »    PDF »
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up.
M. Dittmar and G. J. Kahaly (2003)
J. Clin. Endocrinol. Metab. 88, 2983-2992
   Abstract »    Full Text »    PDF »
Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction.
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta (2002)
Endocr. Rev. 23, 327-364
   Abstract »    Full Text »    PDF »
Exacerbation of Autoantibody-Mediated Hemolytic Anemia by Viral Infection.
M. Meite, S. Léonard, M. E. A. E. Idrissi, S. Izui, P. L. Masson, and J.-P. Coutelier (2000)
J. Virol. 74, 6045-6049
   Abstract »    Full Text »
Retrovirus-Mediated Myelopathies: Are These Autoimmune Disorders Induced by Altered Antigens?.
M. M. Gore, J. P. Thakare, S. N. Ghosh, and R. S. Wadia (1988)
Arch Neurol 45, 601-602
   Abstract »    PDF »
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.
R. Fujinami and M. Oldstone (1985)
Science 230, 1043-1045
   Abstract »    PDF »
Specific endocrine tissue marker defined by a monoclonal antibody.
R. Lloyd and B. Wilson (1983)
Science 222, 628-630
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)